Related Experiment Video

Updated: May 14, 2026

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
08:40

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Published on: March 21, 2017

Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of

Hugo Marcel Vanderstichele, Leslie Shaw, Manu Vandijck

    Clinical Chemistry
    |January 29, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status07:08

    A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

    Published on: October 20, 2016

    Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid10:23

    Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

    Published on: December 4, 2017

    Related Concept Videos

    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...